- Home
- ADTN vs DAWN Comparison
ADTN vs DAWN Comparison
Compare ADTN & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTN
- DAWN
- Stock Information
- Founded
- ADTN 1985
- DAWN 2018
- Country
- ADTN United States
- DAWN United States
- Employees
- ADTN N/A
- DAWN N/A
- Industry
- ADTN Telecommunications Equipment
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- ADTN Telecommunications
- DAWN Health Care
- Exchange
- ADTN Nasdaq
- DAWN Nasdaq
- Market Cap
- ADTN 708.5M
- DAWN 624.8M
- IPO Year
- ADTN 1994
- DAWN 2021
- Fundamental
- Price
- ADTN $7.97
- DAWN $9.75
- Analyst Decision
- ADTN Strong Buy
- DAWN Strong Buy
- Analyst Count
- ADTN 5
- DAWN 8
- Target Price
- ADTN $12.80
- DAWN $26.75
- AVG Volume (30 Days)
- ADTN 2.0M
- DAWN 2.2M
- Earning Date
- ADTN 11-03-2025
- DAWN 11-04-2025
- Dividend Yield
- ADTN N/A
- DAWN N/A
- EPS Growth
- ADTN N/A
- DAWN N/A
- EPS
- ADTN N/A
- DAWN N/A
- Revenue
- ADTN $1,035,099,000.00
- DAWN $133,672,000.00
- Revenue This Year
- ADTN $17.80
- DAWN $12.88
- Revenue Next Year
- ADTN $8.37
- DAWN $48.27
- P/E Ratio
- ADTN N/A
- DAWN N/A
- Revenue Growth
- ADTN 14.33
- DAWN 31.11
- 52 Week Low
- ADTN $6.19
- DAWN $5.64
- 52 Week High
- ADTN $12.44
- DAWN $16.76
- Technical
- Relative Strength Index (RSI)
- ADTN 36.12
- DAWN 74.29
- Support Level
- ADTN $7.88
- DAWN $7.11
- Resistance Level
- ADTN $10.75
- DAWN $10.00
- Average True Range (ATR)
- ADTN 0.49
- DAWN 0.55
- MACD
- ADTN -0.23
- DAWN 0.23
- Stochastic Oscillator
- ADTN 8.06
- DAWN 91.45
About ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.